Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: A Childrens Cancer Group study
- 1 July 1996
- journal article
- clinical trial
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 27 (1) , 15-20
- https://doi.org/10.1002/(sici)1096-911x(199607)27:1<15::aid-mpo4>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic LeukemiaPediatric Hematology and Oncology, 1991
- Home care involving methotrexate infusions for children with acute lymphoblastic leukemiaThe Journal of Pediatrics, 1988
- Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.Archives of Disease in Childhood, 1987
- Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1986
- Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1986
- Intermediate dose methotrexate in childhood acute lymphocytic leukemiaEuropean Paediatric Haematology and Oncology, 1984
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in ChildrenNew England Journal of Medicine, 1983
- INTERMEDIATE DOSE METHOTREXATE (IDM) IN CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA IN NORWAYActa Paediatrica, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958